This process is costly, time-consuming, and has a low success rate. KAIST researchers have developed an AI model that, using only information about the target protein, can design optimal drug ...
The model performs competitively with leading structure-based tools in predicting binding strength, while also generating novel and chemically diverse compounds. SINGAPORE, June 25, 2025 (GLOBE ...
Ainnocence, a leader in next-generation AI drug-discovery solutions, today released a comprehensive white paper detailing persistent scientific obstacles that limit the accuracy and ROI of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback